Skip to main content

The Concept of Heart Failure: Chronic Diseases Accompanied by an Attack of Acute Exacerbation

  • Chapter
  • First Online:
Therapeutic Strategies for Heart Failure

Abstract

Heart failure is an ambiguous technical terminology. It can either refer to the presence of ventricular dysfunction or a decompensated state with symptoms and signs of clinical congestion. Diagnostic criteria for congestive heart failure, called the Framingham criteria, has not been changed for approximately half a century; the therapeutic strategy, however, has been modified considerably, resulting in improved management of congestion and consequent relief of symptoms and signs in heart failure patients. Ironically, that makes the term “heart failure” even more complex and obscure. Chronic heart failure is a new concept that was constructed based on NYHA (New York Heart Association) functional classification to evaluate the degree of symptoms and heart failure stages as per the degree of myocardial remodeling due to neurohumoral activation. This covers all states of heart failure and provides the appropriate management for patients in each stage. A better understanding of the concept of chronic heart failure is beneficial in the clinical management of patients with this condition, not only for cardiologists but also for all attending physicians.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 79.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham Study. N Engl J Med. 1971;285:1441–6.

    Article  CAS  PubMed  Google Scholar 

  2. Editorial. Major changes made by Criteria Committee of The New York Heart Association. Circulation. 1974;49:390.

    Article  Google Scholar 

  3. Hunt SA, Abraham WT, Chin MH, et al. 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009;119:e391–479.

    Article  PubMed  Google Scholar 

  4. Jessup M, Brozena S. Heart failure. N Engl J Med. 2003;348:2007–18.

    Article  PubMed  Google Scholar 

  5. Dargie HJ. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet. 2001;357:1385–90.

    Article  CAS  PubMed  Google Scholar 

  6. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987;316:1429–35.

    Article  Google Scholar 

  7. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced leftventricular ejection fractions. N Engl J Med. 1992;327:685–91.

    Article  Google Scholar 

  8. The SOLVD investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325:293–302.

    Article  Google Scholar 

  9. Jong P, Yusuf S, Rousseau MF, Ahn SA, Bangdiwala SI. Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study. Lancet. 2003;361:1843–8.

    Article  CAS  PubMed  Google Scholar 

  10. Matsumori A. Efficacy and safety of oral candesartan cilexetil in patients with congestive heart failure. Eur J Heart Fail. 2003;5:669–77.

    Article  CAS  PubMed  Google Scholar 

  11. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med. 1996;334:1349–55.

    Article  CAS  PubMed  Google Scholar 

  12. Packer M, Coats AJ, Fowler MB, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 2001;344:1651–8.

    Article  CAS  PubMed  Google Scholar 

  13. Packer M, Fowler MB, Roecker EB, et al. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation. 2002;106:2194–9.

    Article  PubMed  Google Scholar 

  14. Lund LH, Benson L, Dahlstrom U, Edner M. Association between use of renin-angiotensin system antagonists and mortality in patients with heart failure and preserved ejection fraction. JAMA. 2012;308:2108–17.

    Article  CAS  PubMed  Google Scholar 

  15. Bavishi C, Chatterjee S, Ather S, Patel D, Messerli FH. Beta-blockers in heart failure with preserved ejection fraction: a meta-analysis. Heart Fail Rev. 2015;20:193–201.

    Article  CAS  PubMed  Google Scholar 

  16. Pitt B, Pfeffer MA, Assmann SF, et al. Spironolactone for heart failure with preserved ejection fraction. N Engl J Med. 2014;370:1383–92.

    Article  CAS  PubMed  Google Scholar 

  17. Liu F, Chen Y, Feng X, Teng Z, Yuan Y, Bin J. Effects of beta-blockers on heart failure with preserved ejection fraction: a meta-analysis. PLoS One. 2014;9:e90555.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Seidl K, Rameken M, Vater M, Senges J. Cardiac resynchronization therapy in patients with chronic heart failure: pathophysiology and current experience. Am J Cardiovasc Drugs. 2002;2:219–26.

    Article  PubMed  Google Scholar 

  19. Inage T, Yoshida T, Hiraki T, et al. Chronic cardiac resynchronization therapy reverses cardiac remodelling and improves invasive haemodynamics of patients with severe heart failure on optimal medical treatment. Europace. 2008;10:379–83.

    Article  PubMed  Google Scholar 

  20. Fantoni C, Raffa S, Regoli F, et al. Cardiac resynchronization therapy improves heart rate profile and heart rate variability of patients with moderate to severe heart failure. J Am Coll Cardiol. 2005;46:1875–82.

    Article  PubMed  Google Scholar 

  21. Elefteriades JA, Tolis G Jr, Levi E, Mills LK, Zaret BL. Coronary artery bypass grafting in severe left ventricular dysfunction: excellent survival with improved ejection fraction and functional state. J Am Coll Cardiol. 1993;22:1411–7.

    Article  CAS  PubMed  Google Scholar 

  22. Iskandrian S, Gioia G, Pancholy S, Dileva K, Heo J, Iskandrian AS. Prognosis of patients with severe left ventricular dysfunction after coronary artery bypass grafting. Am J Cardiol. 1996;77:199–200.

    Article  CAS  PubMed  Google Scholar 

  23. Carr JA, Haithcock BE, Paone G, Bernabei AF, Silverman NA. Long-term outcome after coronary artery bypass grafting in patients with severe left ventricular dysfunction. Ann Thorac Surg. 2002;74:1531–6.

    Article  PubMed  Google Scholar 

  24. Pereira JJ, Lauer MS, Bashir M, et al. Survival after aortic valve replacement for severe aortic stenosis with low transvalvular gradients and severe left ventricular dysfunction. J Am Coll Cardiol. 2002;39:1356–63.

    Article  PubMed  Google Scholar 

  25. Horskotte D, Schulte HD, Bircks W, Strauer BE. The effect of chordal preservation on late outcome after mitral valve replacement: a randomized study. J Heart Valve Dis. 1993;2:150–8.

    CAS  PubMed  Google Scholar 

  26. Friedrich EB, Bohm M. Management of end stage heart failure. Heart. 2007;93:626–31.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Nakatani T, Fukushima N, Ono M, et al. The registry report of heart transplantation in Japan (1999–2013). Circ J. 2014;78:2604–9.

    Article  PubMed  Google Scholar 

  28. Fukushima N, Ono M, Saito S, et al. Heart donation in Japan before and after the revision of the Japanese Transplantation Act. Transplant Proc. 2014;46:2050–3.

    Article  CAS  PubMed  Google Scholar 

  29. Barge-Caballero E, Segovia-Cubero J, Almenar-Bonet L, et al. Preoperative INTERMACS profiles determine postoperative outcomes in critically ill patients undergoing emergency heart transplantation: analysis of the Spanish National Heart Transplant Registry. Circ Heart Fail. 2013;6:763–72.

    Article  PubMed  Google Scholar 

  30. Saito S, Yamazaki K, Nishinaka T, et al. Post-approval study of a highly pulsed, low-shear-rate, continuous-flow, left ventricular assist device, EVAHEART: a Japanese multicenter study using J-MACS. J Heart Lung Transplant. 2014;33:599–608.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mahoto Kato M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Japan

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kato, M. (2018). The Concept of Heart Failure: Chronic Diseases Accompanied by an Attack of Acute Exacerbation. In: Sato, N. (eds) Therapeutic Strategies for Heart Failure. Springer, Tokyo. https://doi.org/10.1007/978-4-431-56065-4_1

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-56065-4_1

  • Published:

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-56063-0

  • Online ISBN: 978-4-431-56065-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics